EGFR and lip and oral cavity carcinoma: In addition, the anti-oncogene function of miR-218 has been reported in several types of cancers through targeting several oncogenes, such as Rictor (oral cancer), EGFR (non-small cell lung cancer), ROBO1 receptor (gastric cancer) and LAMB3 (cervical cancer) [22–25].